Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS

B. Simon (Budapest, Hungary), B. Gabor (Budapest, Hungary), I. Barta (Budapest, Hungary), C. Paska (Budapest, Hungary), R. Szvatek (Budapest, Hungary), G. Boszormenyi Nagy (Budapest, Hungary), E. Vizi (Budapest, Hungary), B. Antus (Budapest, Hungary)

Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Session: Cardiovascular and metabolic consequences of sleep-disordered breathing
Session type: Thematic Poster
Number: 4333
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Simon (Budapest, Hungary), B. Gabor (Budapest, Hungary), I. Barta (Budapest, Hungary), C. Paska (Budapest, Hungary), R. Szvatek (Budapest, Hungary), G. Boszormenyi Nagy (Budapest, Hungary), E. Vizi (Budapest, Hungary), B. Antus (Budapest, Hungary). Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS. 4333

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of continuous positive airway pressure (nCPAP) on pulmonary hemodynamics in COPD patients with overlap syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 568s
Year: 2004

Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea
Source: Eur Respir J, 50 (2) 1700257; 10.1183/13993003.00257-2017
Year: 2017



Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment
Source: Eur Respir J 2006; 27: 756-760
Year: 2006



Continuous positive airway pressure treatment in patients with OSA
Source: Eur Respir Mon 2010; 50: 244-266
Year: 2010


Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015


Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure
Source: Eur Respir J, 57 (2) 2002524; 10.1183/13993003.02524-2020
Year: 2021



Differential blood pressure response to continuous positive airway pressure treatment according to the circadian pattern in hypertensive patients with obstructive sleep apnoea
Source: Eur Respir J, 54 (1) 1900098; 10.1183/13993003.00098-2019
Year: 2019



Effects of different levels of nasal continuous positive airways pressure (CPAP) in infants with severe acute bronchiolitis
Source: Eur Respir J 2006; 28: Suppl. 50, 264s
Year: 2006

Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients
Source: Eur Respir J 2006; 27: 1229-1235
Year: 2006



Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Screening of sleep apnea-induced hypertension and acute effect of continuous positive airway pressure
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009

Effect of continuous positive airway pressure on 24 h ambulatory blood pressure in hypertensive patients with OSA
Source: Eur Respir J 2007; 30: Suppl. 51, 333s
Year: 2007

Effect and significance of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003


Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 331s
Year: 2004

Effects of continuous positive airways pressure (CPAP) on portal flow in patients with obstructive apnoea syndrome (OSAS)
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007

Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 320s
Year: 2007